Veeva Systems Inc. Class A (VEEV) Peer Comparison
$279.60
$-2.53
(-0.90%)
As on 28-Aug-2026 13:42EDT
Market cap
$40,697 Mln
Revenue (TTM)
$3,319 Mln
P/E Ratio
44.4
P/B Ratio
5.6
Div. Yield
0 %
Edit
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
40,697 | 118,142 | 44,907 | 32,953 | 14,865 |
Revenue ($ Mln) |
3,319 | 36,364 | 7,232 | 5,653 | 4,231 |
Net Profit ($ Mln) |
941.65 | 4,800.00 | 1,414.00 | 1,523.29 | 235.80 |
Net Margin (%) |
28.37 | 13.20 | 19.55 | 26.94 | 5.57 |
RoE (%) |
13.13 | 9.85 | 20.40 | 24.27 | 2.86 |
Price to Earnings |
44.42 | 25.22 | 31.36 | 22.11 | 64.59 |
Price-To-Book |
5.58 | 2.44 | 6.20 | 5.05 | 1.80 |
Income Statement ($ Mln)
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
3,195.31 | 36,364.00 | 6,948.00 | 5,653.44 | 4,092.40 |
|
Cost of Revenue
|
782.02 | 12,721.00 | 3,305.00 | 2,195.77 | 1,609.50 |
|
Gross Profit
|
2,413.29 | 23,643.00 | 3,643.00 | 3,457.68 | 2,482.90 |
|
Operating Expenses
|
1,496.92 | 17,179.00 | 2,164.00 | 1,565.03 | 1,800.00 |
|
Operating Profit (EBIT)
|
916.37 | 6,467.00 | 1,479.00 | 1,892.65 | 682.90 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
1,194.51 | 6,136.00 | 1,435.00 | 1,919.42 | 566.50 |
|
Provision for Tax
|
285.60 | 1,299.00 | 132.00 | 396.12 | 191.60 |
|
Profit after Tax (Net Income)
|
908.91 | 4,800.00 | 1,303.00 | 1,523.29 | 374.90 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 4,662.00 | 1,303.00 | 1,400.72 | -- |
Liabilities ($ Mln)
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
7,214.75 | 49,463.00 | 6,741.00 | 6,585.39 | 8,238.90 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
127.54 | 31,298.00 | 3,639.00 | 985.45 | 3,042.90 |
|
Current Liabilities
|
1,637.06 | 11,658.00 | 2,347.00 | 1,395.11 | 1,112.80 |
|
Total Liabilities
|
8,979.34 | 93,028.00 | 12,727.00 | 8,965.95 | 12,394.80 |
Assets ($ Mln)
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
981.71 | 68,240.00 | 8,133.00 | 4,641.21 | 10,288.40 |
|
Current Assets
|
7,997.63 | 24,787.00 | 4,594.00 | 4,324.74 | 2,106.40 |
|
Total Assets
|
8,979.34 | 93,028.00 | 12,727.00 | 8,965.95 | 12,394.80 |
|
Total Debt*
|
95.86 | 27,961.00 | 3,354.00 | 825.92 | 2,783.60 |
|
Net Current Assets
|
6,360.57 | 13,129.00 | 2,247.00 | 2,486.49 | 993.60 |
Cashflow ($ Mln)
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,415.23 | 7,330.00 | 1,559.00 | 1,805.83 | 796.10 |
|
Cash Flow from Investing Activities
|
-1,104.36 | -2,934.00 | -394.00 | -545.20 | -372.90 |
|
Cash from Financing Activities
|
-9.33 | -4,751.00 | -715.00 | -1,007.03 | -425.90 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.75 | 6.24 | 13.32 | 21.41 | 3.46 |
|
ROE (%)
|
13.93 | 9.85 | 20.62 | 24.27 | 4.59 |
|
ROA (%)
|
11.14 | 5.20 | 10.61 | 17.77 | 3.03 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
28.44 | 13.20 | 18.75 | 26.94 | 9.16 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.16 | 0.08 | 0.07 | 0.10 | 0.05 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
27.27 | 2.96 | 1.09 | 8.75 | -4.44 |
|
EPS Growth (%)
|
-- | -- | -- | 0.10 | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | 18.55 | -- |
|
Price / Book Value
|
-- | -- | -- | 4.29 | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-5.19 | 1.91 | 0.85 | 12.86 | 2.54 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.01 | 0.57 | 0.50 | 0.13 | 0.34 |
|
Short term debt to equity ratio
|
0.00 | 0.04 | 0.05 | 0.04 | 0.01 |
|
Current Ratio
|
4.89 | 2.13 | 1.96 | 3.10 | 1.89 |
|
Quick Ratio
|
-- | 1.62 | 1.52 | 2.42 | 1.13 |
|
Interest Coverage
|
-- | 9.58 | 13.81 | 67.12 | 6.30 |
Operating Efficiency Ratios
| Veeva Systems Inc. Class A (VEEV) | Medtronic PLC (MDT) | Agilent Technologies (A) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
41.01 | 18.27 | 21.40 | 18.33 | 20.26 |
|
Asset Turnover
|
0.39 | 0.39 | 0.57 | 0.66 | 0.33 |
|
Receivable days
|
135.31 | 66.08 | 73.89 | 65.48 | 68.99 |
|
Inventory Days
|
-- | 164.05 | 111.40 | 155.82 | 187.07 |
|
Payable days
|
15.90 | 73.12 | 61.34 | 48.83 | 63.64 |
|
Cash Conversion Cycle
|
-- | 157.01 | 123.95 | 172.47 | 192.42 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
